JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia.
Takahashi Y, Ishida H, Imamura T, Tamefusa K, Suenobu S, Usami I, Yumura-Yagi K, Hasegawa D, Nishimura S, Suzuki N, Hashii Y, Deguchi T, Moriya-Saito A, Kosaka Y, Kato K, Kobayashi R, Kawasaki H, Hori H, Sato A, Kudo T, Nakahata T, Oda M, Hara J, Horibe K.
Takahashi Y, et al. Among authors: tamefusa k.
Int J Hematol. 2022 Jun;115(6):890-897. doi: 10.1007/s12185-022-03315-x. Epub 2022 Mar 8.
Int J Hematol. 2022.
PMID: 35258855